Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07383961Completed

LONG TERM FOLLOW UP AFTER PEDIATRIC SINGLE SITE ROBOTIC CHOLECYSTECTOMY

Role: lead

NCT06842030Not ApplicableNot Yet Recruiting

Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing

Role: lead

NCT05947695Not ApplicableRecruiting

Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer

Role: lead

NCT05944315Not ApplicableUnknown

Injury Prevention Model For K-1 Students

Role: lead

NCT01116882Not ApplicableCompleted

Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings

Role: collaborator

NCT02072421Not ApplicableCompleted

The MASS COMM Post-Randomization Phase Cohort Study

Role: collaborator

NCT01890278Not ApplicableUnknown

Phase II Trial of Conventional Versus IMRT Whole Brain Radiotherapy for Brain Metastases

Role: lead

NCT01704625Not ApplicableUnknown

Will the Use of Osteopathic Manipulative Treatments Help Alleviate Headache Pain

Role: lead

All 8 trials loaded